Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Frydenberg

Showing results (141-150 of 182) with videos related to

Pageof 19
Sort By:
European Urology Open Science|November 10, 2022
Estetrol Prevents Hot Flushes and Improves Quality of Life in Patients with Advanced Prostate Cancer Treated with Androgen Deprivation Therapy: The PCombi StudyYvette Zimmerman, Mark Frydenberg, Hendrik van Poppel, et al.
World Journal of Urology|June 2, 2021
<sup>68</sup>Ga-PSMA-PET screening and transponder-guided salvage radiotherapy to the prostate bed alone for biochemical recurrence following prostatectomy: interim outcomes of a phase II trialPatrick Bowden, Andrew W See, Kevin So, et al.
Biomaterials|April 9, 2013
A bioengineered microenvironment to quantitatively measure the tumorigenic properties of cancer-associated fibroblasts in human prostate cancerAshlee K Clark, Anna V Taubenberger, Renea A Taylor, et al.
BJU International|June 5, 2014
A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy -- Adjuvant Versus Early Salvage (RAVES) trialMaria Pearse, Carol Fraser-Browne, Ian D Davis, et al.
European Urology Open Science|July 11, 2022
Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 InitiativeSebastiaan Remmers, Jozien Helleman, Daan Nieboer, et al.
BMC Cancer|February 13, 2025
A multicentre implementation trial of an Artificial Intelligence-driven biomarker to inform Shared decisions for androgen deprivation therapy in men undergoing prostate radiotherapy: the ASTuTE protocolEric Wegener, Michael Ng, Mario Guerrieri, et al.
European Urology Oncology|July 9, 2026
Quality of Life After Postprostatectomy Radiotherapy: A TROG 08.03 RAVES Randomized Controlled Trial SubstudyJustin Smith, Gill M Duchesne, Andrew Kneebone, et al.
British Journal of Cancer|December 21, 2025
High-dose vitamin D supplementation and prostate cancer progression: a phase II randomised trial in localised prostate cancer cases with intermediate risk of progression (ProsD)Visalini Nair-Shalliker, David P Smith, Val Gebski, et al.
BJU International|July 17, 2021
'Pain-free TRUS B': a phase 3 double-blind placebo-controlled randomized trial of methoxyflurane with periprostatic local anaesthesia to reduce the discomfort of transrectal ultrasonography-guided prostate biopsy (ANZUP 1501)Dickon Hayne, Jeremy Grummet, David Espinoza, et al.
The Prostate|June 19, 2019
Establishing a cryopreservation protocol for patient-derived xenografts of prostate cancerLaura H Porter, Mitchell G Lawrence, Hong Wang, et al.
Pageof 19

Showing results (141-150 of 182) with videos related to

Sort By:
Pageof 19
European Urology Open Science|November 10, 2022
Estetrol Prevents Hot Flushes and Improves Quality of Life in Patients with Advanced Prostate Cancer Treated with Androgen Deprivation Therapy: The PCombi StudyYvette Zimmerman, Mark Frydenberg, Hendrik van Poppel, et al.
World Journal of Urology|June 2, 2021
<sup>68</sup>Ga-PSMA-PET screening and transponder-guided salvage radiotherapy to the prostate bed alone for biochemical recurrence following prostatectomy: interim outcomes of a phase II trialPatrick Bowden, Andrew W See, Kevin So, et al.
Biomaterials|April 9, 2013
A bioengineered microenvironment to quantitatively measure the tumorigenic properties of cancer-associated fibroblasts in human prostate cancerAshlee K Clark, Anna V Taubenberger, Renea A Taylor, et al.
BJU International|June 5, 2014
A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy -- Adjuvant Versus Early Salvage (RAVES) trialMaria Pearse, Carol Fraser-Browne, Ian D Davis, et al.
European Urology Open Science|July 11, 2022
Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 InitiativeSebastiaan Remmers, Jozien Helleman, Daan Nieboer, et al.
BMC Cancer|February 13, 2025
A multicentre implementation trial of an Artificial Intelligence-driven biomarker to inform Shared decisions for androgen deprivation therapy in men undergoing prostate radiotherapy: the ASTuTE protocolEric Wegener, Michael Ng, Mario Guerrieri, et al.
European Urology Oncology|July 9, 2026
Quality of Life After Postprostatectomy Radiotherapy: A TROG 08.03 RAVES Randomized Controlled Trial SubstudyJustin Smith, Gill M Duchesne, Andrew Kneebone, et al.
British Journal of Cancer|December 21, 2025
High-dose vitamin D supplementation and prostate cancer progression: a phase II randomised trial in localised prostate cancer cases with intermediate risk of progression (ProsD)Visalini Nair-Shalliker, David P Smith, Val Gebski, et al.
BJU International|July 17, 2021
'Pain-free TRUS B': a phase 3 double-blind placebo-controlled randomized trial of methoxyflurane with periprostatic local anaesthesia to reduce the discomfort of transrectal ultrasonography-guided prostate biopsy (ANZUP 1501)Dickon Hayne, Jeremy Grummet, David Espinoza, et al.
The Prostate|June 19, 2019
Establishing a cryopreservation protocol for patient-derived xenografts of prostate cancerLaura H Porter, Mitchell G Lawrence, Hong Wang, et al.
Pageof 19